Pfizer to pay $325 million in Neurontin settlement

(Reuters) - Pfizer Inc has agreed to pay $325 million to resolve claims it defrauded insurers and other healthcare benefit providers by marketing Neurontin for unapproved uses, its second settlement over the epilepsy drug in six weeks.

http://feedproxy.google.com/~r/reuters/healthNews/~3/jCj-dAyUcik/story01.htm

Source: Reuters: Health - June 2, 2014 Category: Consumer Health News Tags: healthNews Source Type: news